Rockwell Medical (RMTI) Operating Expenses (2010 - 2026)
Rockwell Medical (RMTI) posted Operating Expenses of $4.4 million for Q1 2026, up 2.36% on a QoQ basis from $4.3 million in Q4 2025, and down 0.57% year-over-year from $4.4 million in Q1 2025.
Rockwell Medical (RMTI) Operating Expenses (2010 - 2026) Analysis & Trends
Rockwell Medical's Operating Expenses history runs 17 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- Quarterly Operating Expenses fell 0.57% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.4 million (down 12.87% YoY) and the FY2025 annual result came in at $16.4 million, down 2.79% from the prior year.
- Operating Expenses was $4.4 million for Q1 2026 at Rockwell Medical, up from $4.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $6.0 million in Q4 2024 and bottomed at $2.9 million in Q4 2023.
- A 5-year average of $4.1 million and a median of $4.0 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses tumbled 31.34% — and 2024, when it surged 110.42%.
- Rockwell Medical's Operating Expenses stood at $2.9 million in 2022, then retreated by 2.08% to $2.9 million in 2023, then jumped by 110.42% to $6.0 million in 2024, then decreased by 29.17% to $4.3 million in 2025, then climbed by 2.36% to $4.4 million in 2026.
- Business Quant data shows RMTI's Operating Expenses at $4.4 million in Q1 2026, $4.3 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 4.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.38 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.85 Mn |
| Mar 31, 2025 | 4.40 Mn |
| Dec 31, 2024 | 6.04 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 4.04 Mn |
| Mar 31, 2024 | 4.37 Mn |
| Dec 31, 2023 | 2.87 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 3.72 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 4.27 Mn |
| Dec 31, 2021 | 4.15 Mn |
| Sep 30, 2021 | 5.42 Mn |
| Jun 30, 2021 | 6.09 Mn |